close

Mergers and Acquisitions

1 25 26 27 28 29 33
Number of results: 648
Date Acquired company Acquiring company Amount Related
2013-02-21 AROS Applied Biotechnology (Denmark) Eurofins Scientific (Luxembourg)

Genomic services

2013-02-04 clinical trial services division of Cross Country Healthcare (USA) Icon (Ireland) $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones

clinical research

2013-02-01 Confarma Solvias (Switzerland) undisclosed

analytical services
CRO

2013-01-25 Pierrel Research International (Contract Research Organization of Pierrel - Italy) mondoBIOTECH (Switzerland)

Clinical research
CRO

2013-01-15 Cangenix (UK) Galapagos (Belgium) £1 million, with a further £440,000 potential earn out payment contingent upon achievement of certain conditions

Services
R&D

2013-01-08 Lotus Tissue Repair (USA) Shire (UK - USA) undisclosed (upfront payment and certain contingent payments based on the achievement of certain safety and development milestones)

Rare diseases

2013-01-08 Aureus Sciences (France) Elsevier (The Netherlands) undisclosed

Databases
Drug discovery
R&D

2013-01-04 U.S. Animal Health Business From Teva Pharmaceutical Industries (Israel) Bayer (Germany) $ 145 million (€ 110.45 million)

Animal healthcare
Veterinary industry
Animal food

2013-01-03 Cell Culture Service (Germany) Evotec (Germany) €1.15 million plus an earn-out payment dependent on business Performance

services

2013-01-02 Quotient Bioresearch's Bioanalytical Sciences division (UK) LGC Standards (UK) undisclosed

Bioanalytical services

2012-12-26 CV Ingenuity (USA) Covidien (Ireland) undisclosed

Medical devices

2012-12-21 Cerep (France) Eurofins Scientific (Luxembourg) € 25.2 million

services
pharmacology

2012-12-21 minority share in Karolinska Development’s holdings in 13 of its 25 portfolio companies Rosetta Capital (UK) SEK 220 million (€25.5 million)
2012-12-20 Dosch Pharmaceuticals (India) Merial, a Sanofi company (France) Financial details were not disclosed.

Veterinary medicine

2012-12-20 Dendreon's manufacturing facility (USA - NJ) Novartis (Switzerland) $43 million (€32.5 million)

Manufacturing
Bioproduction

2012-12-19 Harrison Clinical Research (Germany) Synteract (USA) undisclosed

CRO

2012-12-17 NeuroNova (Sweden) Newron (Italy) €16 million

Neurodegenerative diseases

2012-12-16 AbD Serotec, MorphoSys's Research and Diagnostic Antibody Business (Germany) Bio-Rad (USA) € 53 million

diagnostic

2012-12-16 Intercell (Austria) Vivalis (France) €133 million

vaccines
antibodies

2012-12-14 portfolio of Lundbeck’s (Denmark) non-core products primarily related to the United States Recordati (Italy) up to $100 million (€76 million)

drug industry
pharmaceuticals